6,564 Shares in Celestica, Inc. $CLS Bought by Eleva Capital SAS

Key Points

• Eleva Capital SAS initiated a Celestica position by purchasing 6,564 shares worth approximately $2.37 million, making CLS about 2% of its portfolio. Institutional investors collectively own 67.38% of the company.
• Celestica reported strong quarterly results, with revenue rising 62.4% year over year to $4.68 billion and EPS of $2.54, surpassing analyst expectations of $2.29.
• Analysts remain broadly bullish, with 23 Buy ratings and one Hold; the stock has a consensus “Moderate Buy” rating and an average price target of $450.50. However, company insiders sold about 243,067 shares worth $89.2 million over the past 90 days.

Eleva Capital SAS bought a new position in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 6,564 shares of the technology company's stock, valued at approximately $2,372,000. Celestica makes up approximately 2.0% of Eleva Capital SAS's investment portfolio, making the stock its 12th biggest holding.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of Celestica by 24.8% in the fourth quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock worth $1,187,650,000 after buying an additional 798,782 shares in the last quarter. Cibc World Market Inc. bought a new position in Celestica in the 2nd quarter worth about $757,811,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Celestica in the 2nd quarter valued at about $674,199,000. Franklin Resources Inc. boosted its position in shares of Celestica by 18.6% during the 4th quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company's stock valued at $673,471,000 after acquiring an additional 356,797 shares during the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Celestica during the second quarter worth about $444,899,000. 67.38% of the stock is owned by institutional investors.

Celestica Trading Down 0.0%

Shares of CLS stock traded down $0.05 on Tuesday, hitting $382.64. 538,842 shares of the company's stock traded hands, compared to its average volume of 2,413,344. The stock has a market capitalization of $44.00 billion, a price-to-earnings ratio of 39.76 and a beta of 2.01. The company's fifty day simple moving average is $331.68 and its 200 day simple moving average is $346.70. Celestica, Inc. has a one year low of $230.24 and a one year high of $474.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, beating analysts' consensus estimates of $2.29 by $0.25. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The company had revenue of $4.68 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same quarter in the previous year, the company posted $1.39 EPS. Celestica's revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Equities analysts forecast that Celestica, Inc. will post 10.71 EPS for the current year.

Insider Buying and Selling

In other Celestica news, CFO Mandeep Chawla sold 16,117 shares of the firm's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $369.32, for a total transaction of $5,952,330.44. Following the completion of the transaction, the chief financial officer owned 65,444 shares of the company's stock, valued at approximately $24,169,778.08. This trade represents a 19.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Robert Mionis sold 23,396 shares of the company's stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $364.22, for a total transaction of $8,521,291.12. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 243,067 shares of company stock valued at $89,200,967 over the last ninety days. Company insiders own 1.10% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. TD Cowen restated a "buy" rating on shares of Celestica in a research report on Wednesday, September 16th. Barclays cut their price target on shares of Celestica from $430.00 to $406.00 and set an "overweight" rating for the company in a research note on Friday, August 7th. JPMorgan Chase & Co. raised their price objective on shares of Celestica from $445.00 to $485.00 and gave the company an "overweight" rating in a research report on Wednesday, July 29th. UBS Group raised shares of Celestica from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $410.00 to $430.00 in a report on Monday, August 24th. Finally, Wolfe Research upped their target price on shares of Celestica from $425.00 to $475.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 29th. Twenty-three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $450.50.

Celestica Company Profile

Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply-chain services for original equipment manufacturers and other technology companies. The company helps customers develop, produce, deploy, and support complex hardware and electronic systems, serving industries such as communications, enterprise technology, aerospace and defense, industrial technology, health care, and semiconductor equipment.

Its services include product design and engineering, printed circuit board and systems assembly, manufacturing, testing, logistics, aftermarket support, and supply-chain management.

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.